CRISPR-AI Integration and Screening Services

Leverage our proprietary AI models, fine-tuned on proprietary genomic datasets, to design CRISPR guides with optimized on-target efficiency and minimized off-target effects. This reduces experimental noise and increases the signal-to-noise ratio in your screening campaigns.

Our AI-driven analysis platforms rapidly process high-content screening data (imaging, sequencing) to identify true phenotypic hits and complex genetic interactions, compressing analysis timelines from weeks to days.

Predictive off-target scoring and in-silico saturation mutagenesis simulations allow for smarter, more informed experimental design. This minimizes costly, time-consuming wet-lab cycles to validate and optimize edits.

We engineer seamless MLOps pipelines that connect guide design, experimental data ingestion, and model retraining. This creates a closed-loop, reproducible system that continuously improves with your data, ensuring long-term R&D asset value. Learn more about our approach to Bio-AI Data Pipeline and MLOps Engineering.

Our platforms are built with data integrity, lineage tracking, and model validation frameworks from the start. This creates the robust documentation and reproducible analysis trails required for preclinical regulatory submissions and IP protection.

Go beyond single experiments. Our systems integrate public and proprietary biological knowledge bases using Retrieval-Augmented Generation (RAG) to provide context-aware insights, connecting your screening results to known pathways, literature, and compound libraries. This approach is foundational to our broader Multimodal Bio-Data Fusion AI Integration services.

We implement and fine-tune state-of-the-art models (e.g., CRISPR-Net, DeepCRISPR) to design high-specificity guide RNAs. Our systems predict on-target efficiency and off-target effects with >90% accuracy, validated against public datasets like CRISPR-Cas9 screen repositories. This reduces experimental iteration cycles by up to 70%.

Our custom computer vision pipelines automate the quantification of complex cellular phenotypes from microscopy images. We deploy models trained on domain-specific data to extract features, classify hits, and identify subtle morphological changes, turning terabytes of image data into structured, queryable insights in hours.

We build multimodal AI systems that correlate CRISPR screening hits with transcriptomic, proteomic, and epigenomic data. Using graph neural networks, we model gene regulatory networks and pathway interactions to prioritize targets and elucidate mechanism of action, providing a systems-level view of gene function.

We engineer robust Bio-AI Data Pipeline and MLOps Engineering for your CRISPR workflows. This includes version-controlled model registries, automated data validation, and containerized deployment to on-premise HPC or cloud, ensuring every experiment and prediction is fully reproducible and audit-ready for regulatory submission.

We architect agentic AI systems that analyze screening results, propose follow-up experiment designs (e.g., combinatorial knockouts, dose-response), and automatically generate protocols for integrated lab robotics. This creates a self-improving R&D cycle, continuously refining hypotheses and maximizing information gain per experiment.

Our development process embeds principles from Bio-AI Regulatory Compliance and Validation. We implement rigorous model validation suites, maintain comprehensive data lineage tracking, and generate audit trails for all AI-driven decisions, ensuring your platform meets standards for eventual diagnostic or therapeutic application.